Ten new briarane diterpenoids, briaviolides A-J (1-10), together with six known briaranes, solenolides A and D, excavatolide A, briaexcavatolide I, 4β-acetoxy-9-deacetystylatulide lactone and 9-deacetylstylatulide lactone, were isolated from the Taiwanese soft coral, Briareum violacea. Their structures were determined on the basis of spectroscopic data ( 1 H-and 13 C-NMR, 1 H-1 H COSY, HSQC, HMBC and NOESY), HR-MS and chemical methods. The absolute configuration of briaviolide A (1) was determined by X-ray crystallographic analysis. Compounds 5, 9 and derivative 11 showed moderate inhibitory activities on superoxide-anion generation and elastase release by human neutrophils in response to N-formyl-methionyl-leucyl-phenylalanine/ Cytochalasin B (fMLP/CB).
Introduction
The briarane diterpenoids [1] continue to attract the attention of natural product chemists because of their structural complexity and interesting biological activities, such as anti-inflammatory [2] , antiviral [3] , cytotoxic [4] [5] [6] , antifouling [7, 8] , immuno-modulatory [9] , insecticidal [10] and reversal of multidrug resistance [11] . The structures of these diterpenoids are characterized by a highly oxygenated bicyclo [8.4 .0]tetradecane skeleton that is frequently attached with a γ-lactone moiety. Since the first structural elucidation of briarein A isolated from Briareum asbestinum in 1977 [12] , more than 450 briarane-type diterpenoids have been reported from Octocorallia, including Gorgonacea, Pennatulacea, Alcyonacea and Stolonifera [13] [14] [15] . In serial studies of the Taiwanese gorgonian corals, many new briaranes have been isolated, including juncenolides A-G from Junceella juncea [16] [17] [18] , frajunolides A-K from J. fragilis [19, 20] and briaviodiol A from B. violacea [21] .
In this paper, we report the investigation of Taiwanese soft coral Briareum violacea that provided ten new briarane-type diterpenoids, briaviolides A-J (1-10) (Figure 1 ), along with six known analogues, solenolides A and D, excavatolide A, briaexcavatolide I, 4β-acetoxy-9-deacetystylatulide lactone and 9-deacetylstylatulide lactone. The structures of new compounds were established by spectroscopic and chemical methods. Among them, the structure of 1 was further confirmed by single-crystal X-ray analysis. The in vitro anti-inflammatory activities of new compounds (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) and new derivative 11 were also tested for their inhibition of elastase release and superoxide-anion generation from human neutrophils. 
Results and Discussion
Briaviolide A (1) was isolated as colorless prisms. Its ESIMS revealed two isotopic [ yielded a monobenzoyl derivative 11 that confirmed the secondary hydroxyl group at C-12.
The relative configuration of 1 was determined by NOESY ( Figure 3a ) and X-ray diffraction analysis ( Figure 3b ). Naturally occurring briaranes have β-face of Me-15 and α-orientation of H-10. The NOESY correlations between H-2/H-16, H-2/H-10, H-10/H-12, H-12/H-11, H-11/H-9 and H-9/Me-19 required that all of these groups were in α-face, and correlations of H-6/H-7, H-7/H-17, Me-15/H-14 and H-14/H-13 indicated β-disposition for these groups. The correlations between H-16/H-2 and H-2/H-10 suggested that the conjugated diene had a s-cis geometry and forced the ten-membered ring to adopt a boat-like conformation with C-1 and C-5 at the bow and stern positions. An X-ray crystallographic analysis established the complete structure and stereochemistry of 1 as shown by the Oak Ridge Thermal Ellipsoid Plot (ORTEP) diagram stereo-drawing in Figure 3b . The negative optical rotation value of 1 was similar to that of briaexcavatolide I [23] in direction and magnitude, suggesting that 1 and briaexcavatolide I had 1S,10S-configurations in the ring junction. Thus, the structure of briaviolide A (1) was determined as (1S,2S,3Z,6S,7R,8R,9S,10S,11R,12R,13S,14R , 17R)-6-chloro-13,14-epoxy-2,9-diacetoxy-8,12-dihydroxybriaran-3(4),5(16)-dien-18,7-olide. Briaviolide G (7) had the molecular formula C 26 H 33 O 11 Cl, as determined by HRESIMS analysis. It was found that the 1 H-, 13 C-NMR (Tables 1 and 2 ) and IR spectroscopic data were very similar to those of Compound 6. However, the hexanoate group at C-12 in 6 was replaced by an acetyl group at C-2 in 7. [26] , the configuration of 12-OH could be assigned ( Figure 5 ). By comparison of the coupling constant of H-12/H-13 and the chemical shift of C-20, as well as the NOESY correlation between H-12 and Me-20 (δ H 1.06), the acetyl group at C-12 was assigned to be α-face. The other NOSEY correlations (Figure 4 ) also indicated that Compound 7 had identical configurations as those of 6. Therefore, 7 was assigned a 2β-acetoxyl-12α-acetoxyl derivative of Compound 6. Briaviolide H (8) was obtained as an amorphous gum. The molecular formula of 8 was determined as C 24 (Figure 2 ) revealed that 9-and 12-acetyl groups in frajunolide A were replaced by hydroxyl groups in 8. The NOESY correlations of H-2/H-10, H-10/H-9 and Me-19 in 8 suggested that the configurations of them were α-oriented. On the other hand, the correlations of H-6/H-7, H-7/H-17, H-14/Me-15 agreed with a β-configuration of H-7, H-14, Me-15 and H-17. The large coupling constant (J 6,7 = 9.6 Hz) confirmed the anti-parallel arrangement of H-6 and H-7 and the β-orientation of H-7 [19] . It was concluded that briaviolide H (8) has the structure of (1S,2S,6Z,7S,8R,9S,10S,12S,14S,17R)-2,14-diacetoxy-12-hydroxy-8,9-dihydroxybriaran-5 (6)-dien-18,7-olide. The molecular formula C 24 H 34 O 10 was assigned to Compound 9 from its HRESIMS and 13 C NMR data ( Table 2 ). The spectroscopic values of 9 suggested a briarane structure similar to that of 8 with one additional hydroperoxy group at C-12 (δ C 83.8). The configuration of Compound 9 was further determined by the NOESY experiments (Figure 4) , and the correlations revealed that 9 possessed the same relative configurations as those of 8. Thus, briaviolide I (9) was assigned as 12-hydroperoxyl derivative of Compound 8. Briaviolide J (10) had the molecular formula C 26 H 36 O 10 , as determined by its HRESIMS and DEPT 13 C NMR data. The IR absorptions of 10 were found at 3426, 1732 and 1675 cm −1 , which indicated the presence of hydroxyl, a γ-lactone and ester groups. The 1 H-and 13 C-NMR data (Tables 1 and 2) revealed that 10 was an 8-hydroxybriarane-type diterpenoid and was structurally similar to 8 and 9.
Comparisons of their NMR and MS data showed that the only difference between 8 and 10 was the presence of an acetate group at C-12 in 10. Acetylation of 8 afforded a product identical to Compound 10. Thus, it was concluded that 10 is 12-acetoxyl derivative of Compound 8.
In addition, six known briaranes, solenolides A and D [25] , excavatolide A [26] , briaexcavatolide I [22] , 4β-acetoxy-9-deacetystylatulide lactone and 9-deacetylstylatulide lactone [27] , were identified. The new isolated briaranes 1-10 and derivative 11 were evaluated for anti-inflammatory activities on superoxide-anion generation and elastase release by human neutrophils in response to N-formyl-methionyl-leucyl-phenylalanine (fMLP)/Cytochalasin B (CB). The inhibition percentages of these compounds at the concentration of 10 μg/mL are summarized in Table 3 . The bioassay data showed that Compounds 5 and 9 have moderate activities on both of superoxide-anion generation and elastase release, while Compound 11 has selective activity on the inhibition of elastase release. 52.45 ± 6.34 a At a concentration of 10 μg/mL for each compound. Results are presented as the mean ± SEM (n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001 compared with the control value; b Positive control.
Experimental Section

General Experimental Procedures
The melting point was measured on a BÜCHI Melting Point B-540 apparatus (Buchi, Flawil, Switzerland) and uncorrected. Optical rotations were recorded on a JASCO DIP-1020 polarimeter (Jasco, Tokyo, Japan). IR spectra were measured on a JASCO FT/IR-4100 spectrophotometer (Jasco, Tokyo, Japan). HR-ESI-MS were taken on a JEOL JMS-HX 110 mass spectrometer (Jeol, Tokyo, Japan). The NMR spectra were recorded either on a Bruker Avance 300, or a 400 NMR spectrometer, or on a Varian MR 400 NMR spectrometer (Varian, Santa Clara, CA, USA). The chemical shifts were given in δ (ppm) and coupling constants in Hz. Silica gel 60 (Merck, Darmstadt, Germany) was used for column chromatography (CC), and pre-coated silica gel plates (Merck, Darmstadt, Germany, Kieselgel 60 F-254, 1 mm) were used for preparative TLC. Sephadex LH-20 (Amersham Pharmacia Biotech AB, Sweden) was used for separation. LiChrospher ® Si 60 (5 μm, 250-10, Merck, Darmstadt, Germany) and LiChrospher ® 100 RP-18e (5 μm, 250-10, Merck, Darmstadt, Germany) were used for NP-HPLC and RP-HPLC (Merck, Darmstadt, Germany), respectively.
Animal Material
The gorgonian, Briareum violacea (Quoy and Gaimard), was collected in Pingtong County of southern Taiwan by scuba diving at a depth of 15 m, in May 2007. The fresh gorgonian was immediately frozen after collection and kept at −20 °C until being processed. A voucher specimen was deposited in the School of Pharmacy, College of Medicine, National Taiwan University.
Extraction and Isolation
The gorgonian, B. violacea (wet weight, 2.5 kg), was minced and extracted with acetone/MeOH (3 × 5 L) at room temperature, and the extracts were combined and concentrated under vacuum. The dark green crude residue was partitioned between EtOAc and H 2 O (1:1). The EtOAc-soluble portion was shaken with n-hexane/MeOH/H 2 O (4:3:1), and the MeOH layer (15 g) was evaporated and separated on Sephadex LH-20 to give eight fractions (L1 to L8). Fraction L3 (9.5 g) was subjected to flash column chromatography using silica gel and a gradient of n-hexane/EtOAc/MeOH to obtain 25 fractions (L3-1 to L3-25). Crystallization of L3-16 (n-hexane/EtOAc, 2:1; 640 mg) furnished 9-deacetylstylatulide lactone (123 mg). The MeOH-soluble portion of fraction L3-16 was separated on C 18 reversed-phase (RP) HPLC using MeOH/H 2 O/CH 3 CN (50:45:10) to yield Compound 5 (9 mg), excavatolide A (6.5 mg) and stylatulide lactone (2 mg). Fraction L3-17 (n-hexane/EtOAc, 3:2; 1.6 g) was separated by RP-HPLC using MeOH/H 2 O/CH 3 CN (50:50:5) to afford Compound 6 (8.7 mg). Fraction L3-18 (n-hexane/EtOAc, 1:1; 2.0 g) was subjected to column chromatography using silica gel and a gradient of n-hexane/EtOAc/MeOH to obtain 10 fractions (L3-18-1 to L3-18-10). Fraction L3-18-2 (185 mg) was subjected to RP-HPLC using MeOH/H 2 O/CH 3 
Conclusions
Sixteen briarane diterpenoids, including ten new compounds briaviolides, A-J (1-10), were successfully isolated from the Taiwanese soft coral, Briareum violacea, and their structures determined. The inhibitory effects of the isolates and new derivative 11 on superoxide-anion generation and elastase release by human neutrophils in response to fMLP/CB were evaluated. Compounds 5 and 9 showed moderate anti-inflammatory activities at a concentration of 10 μg/mL. Compound 11, derived from Compound 1, showed better inhibition of elastase release than that of 1. Further comparison of the activities of those compounds may suggest that β-orientation and the chain length of ester groups at C-12 are important for the anti-inflammatory activities in briarane-type diterpenoids.
